ScreenerHero

RTALB RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.

BIST · TR · Healthcare · Biotechnology · rtalabs.com.tr
2.420TRY+10.00%Mkt Cap: 28.93M $P/E: —

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. engages in the research, development, and production of microbiology and molecular biology products in Turkey. It offers real-time PCR kits, nuclei…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap28.93M USD
Enterprise Value24.89M USD
Revenue (TTM)6.52M USD
Gross Profit1.98M USD
Net Income (TTM)21.07M USD
Revenue/Share0.55 TRY
Last Price2.420 TRY
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees73
CountryTR
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA82.56
EV/Revenue3.82
P/S4.03
P/B0.38
EPS (TTM)-0.06
EPS (Forward)—
52W Range
1.84018% of range5.080
52W High5.080 TRY
52W Low1.840 TRY
Profitability
Gross Margin34.60%
Oper. Margin-25.34%
EBITDA Margin4.62%
Profit Margin367.83%
ROE29.72%
ROA25.66%
Growth
Revenue Growth27.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF3.69M USD
CapEx (TTM)799.20K USD
FCF Margin-25.76%
FCF Yield-5.81%
Net Debt-1.42M USD
Net Debt/EBITDA-4.70
Balance Sheet
Debt/Equity0.04
Current Ratio4.80
Quick Ratio3.68
Book Value/Sh5.85 TRY
Cash/Share0.16 TRY
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 TRY
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split500:100
Split DateMar 19, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.500.00M
Float350.00M
Insiders16.59%
Institutions0.03%
Technical
SMA 502.692 (-10.1%)
SMA 2003.443 (-29.7%)
Beta0.48
S&P 52W Chg16.45%
Avg Vol (30d)25.52M
Avg Vol (10d)20.33M
Technical Indicators
RSI (14)52.4
MACD-0.1815
MACD Signal-0.2272
MACD Hist.+0.0457
BB Upper2.988 TRY
BB Middle2.279 TRY
BB Lower1.569 TRY
BB Width62.30%
ATR (14)0.1606 TRY
Vol Ratio (20d)1.48x